BRPI0911634A2 - processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas - Google Patents

processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas

Info

Publication number
BRPI0911634A2
BRPI0911634A2 BRPI0911634A BRPI0911634A BRPI0911634A2 BR PI0911634 A2 BRPI0911634 A2 BR PI0911634A2 BR PI0911634 A BRPI0911634 A BR PI0911634A BR PI0911634 A BRPI0911634 A BR PI0911634A BR PI0911634 A2 BRPI0911634 A2 BR PI0911634A2
Authority
BR
Brazil
Prior art keywords
carboxamides
pyrrol
pyrimidin
aryl
amino
Prior art date
Application number
BRPI0911634A
Other languages
English (en)
Inventor
Carlo Battistini
Ermes Vanotti
Maria Gioia Fornaretto
Matteo D Anello
Original Assignee
Nerviano Medical Sciences Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences Srl filed Critical Nerviano Medical Sciences Srl
Publication of BRPI0911634A2 publication Critical patent/BRPI0911634A2/pt
Publication of BRPI0911634B1 publication Critical patent/BRPI0911634B1/pt
Publication of BRPI0911634B8 publication Critical patent/BRPI0911634B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BRPI0911634A 2008-04-30 2009-04-30 processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas BRPI0911634B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08155501 2008-04-30
IT08155501.3 2008-04-30
PCT/EP2009/055262 WO2009133170A1 (en) 2008-04-30 2009-04-30 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides

Publications (3)

Publication Number Publication Date
BRPI0911634A2 true BRPI0911634A2 (pt) 2016-06-14
BRPI0911634B1 BRPI0911634B1 (pt) 2021-05-04
BRPI0911634B8 BRPI0911634B8 (pt) 2021-05-25

Family

ID=40897697

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911634A BRPI0911634B8 (pt) 2008-04-30 2009-04-30 processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas

Country Status (14)

Country Link
US (1) US8399668B2 (pt)
EP (1) EP2285801B1 (pt)
JP (1) JP5490100B2 (pt)
KR (1) KR20110044835A (pt)
CN (1) CN102036983B (pt)
AU (1) AU2009242076B2 (pt)
BR (1) BRPI0911634B8 (pt)
CA (1) CA2723209C (pt)
EA (1) EA019036B1 (pt)
ES (1) ES2436433T3 (pt)
IL (1) IL208951A0 (pt)
MX (1) MX2010011456A (pt)
TW (1) TWI426074B (pt)
WO (1) WO2009133170A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2173728A2 (en) 2007-07-17 2010-04-14 Amgen Inc. Heterocyclic modulators of pkb
US7919504B2 (en) 2007-07-17 2011-04-05 Amgen Inc. Thiadiazole modulators of PKB
WO2010108921A1 (en) * 2009-03-27 2010-09-30 Nerviano Medical Sciences S.R.L. N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
JP5715146B2 (ja) * 2009-11-04 2015-05-07 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ 5−(2−アミノ−ピリミジン−4−イル)−2−アリール−1h−ピロール−3−カルボキサミドの調製方法
CN102666528B (zh) * 2009-11-11 2014-04-16 内尔维阿诺医学科学有限公司 晶体cdc7 抑制剂盐
TW201127384A (en) 2009-11-18 2011-08-16 Nerviano Medical Sciences Srl Therapeutic combination comprising a Cdc7 inhibitor and an antineoplastic agent
JP5970537B2 (ja) * 2011-04-19 2016-08-17 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ キナーゼ阻害薬として活性な置換ピリミジニル−ピロール
JP6016915B2 (ja) * 2011-07-28 2016-10-26 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ キナーゼ阻害剤として活性なアルキニル置換ピリミジニルピロール
WO2022174031A1 (en) * 2021-02-12 2022-08-18 Relay Therapeutics, Inc. Cdk inhibitors and methods of use thereof
CN117157289A (zh) * 2021-04-02 2023-12-01 内尔维亚诺医疗科学公司 被取代的吡咯甲酰胺、其制备工艺及其作为激酶抑制剂的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA805280B (en) * 1979-08-27 1982-04-28 Du Pont Antiinflammatory 4,5-diaryl-a-polyfluoroalkyl-1h-pyrrole-2-methanols and 1-(4,5-diaryl-1h-pyrrol-2-yl)polyfluoralkanones
US5284863A (en) * 1991-12-04 1994-02-08 American Cyanamid Company Haloalkylthio, -sulfinyl and -sulfonyl arylpyrrole fungicidal agents
JPH06135961A (ja) * 1992-10-23 1994-05-17 Nippon Iyakuhin Kogyo Kk 新規ジフェニルピロリルフラン誘導体
US5559137A (en) * 1994-05-16 1996-09-24 Smithkline Beecham Corp. Compounds
GB0121488D0 (en) * 2001-09-05 2001-10-24 Smithkline Beecham Plc Compounds
GB0229243D0 (en) * 2002-12-16 2003-01-22 Avecia Ltd Compounds and process
BR122019010200B8 (pt) * 2003-05-22 2021-07-27 Nerviano Medical Science S R L compostos de pirazol-quinazolina, seus sais, produtos ou kits e composições farmacêuticas
WO2005095386A1 (en) * 2004-03-30 2005-10-13 Chiron Corporation Substituted thiophene derivatives as anti-cancer agents
CA2596737A1 (en) * 2005-03-21 2006-09-28 Eisai R & D Management Co., Ltd. Pyrimidine compound crystal or amorphous form and process for producing the same
BRPI0709680B8 (pt) * 2006-03-27 2021-05-25 Nerviano Medical Sciences Srl derivados de pirrol, tiofeno e furano substituídos por piridil e piridimil como inibidores de quinase

Also Published As

Publication number Publication date
CN102036983A (zh) 2011-04-27
US20110040090A1 (en) 2011-02-17
AU2009242076B2 (en) 2013-10-10
AU2009242076A1 (en) 2009-11-05
CN102036983B (zh) 2014-02-19
CA2723209C (en) 2016-06-21
JP2011518866A (ja) 2011-06-30
EP2285801A1 (en) 2011-02-23
EP2285801B1 (en) 2013-10-09
EA201071252A1 (ru) 2011-06-30
MX2010011456A (es) 2010-11-30
BRPI0911634B1 (pt) 2021-05-04
TW200951124A (en) 2009-12-16
ES2436433T3 (es) 2014-01-02
KR20110044835A (ko) 2011-05-02
BRPI0911634B8 (pt) 2021-05-25
CA2723209A1 (en) 2009-11-05
TWI426074B (zh) 2014-02-11
EA019036B1 (ru) 2013-12-30
IL208951A0 (en) 2011-01-31
US8399668B2 (en) 2013-03-19
JP5490100B2 (ja) 2014-05-14
HK1151794A1 (en) 2012-02-10
WO2009133170A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
BRPI0916609A2 (pt) Processo para a preparação de um macrociclo
BRPI0911254A2 (pt) processo para a preparação de um composto
BRPI0911634A2 (pt) processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0921466A2 (pt) processo para a fabricação de metacrilato de metila derivado de biomassa
BRPI0910910A2 (pt) processo para preparar um composto
BRPI0910911A2 (pt) processo para preparar um composto
BRPI0920356A2 (pt) Processo para a preparação de compostos úteis como inibidores de sglt
BRPI0816258A2 (pt) processo para a preparação de compostos úteis como inibidores de sglt
BRPI0821944A2 (pt) Processo
BRPI0919868A2 (pt) processo
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI0921374A2 (pt) processo
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI0812422A2 (pt) Processo de preparação de um aldeído hidroxiaromático
BRPI0914674A2 (pt) processo para preparação de um pó
BRPI0815784A2 (pt) Processo para a preparação de 1,2-propanodiol
BRPI0909393A2 (pt) processo para a preparação de polibutadieno
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
BRPI0921420A2 (pt) processo para preparar compostos
BR112012001462A2 (pt) processo para preparar metil mercaptano.
BRPI0922836A2 (pt) processo para a preparação de um sal de succinato monovalente
BRPI0815971A2 (pt) Processo para a preparação de 1,2-propanodiol
BRPI0920689A2 (pt) processo para produção de cumeno

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE. PAGAR RESTAURACAO.

B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 870160058967 DE 11/10/2016 , EM VIRTUDE DO DISPOSTO NO ARTO 219, INCISO II DA LPI.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2385 DE 20/09/2016

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/04/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2825 DE 25-02-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.